Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase
Schwabe, U.; Berndt, S.; Ebert, R.
Naunyn-Schmiedeberg's Archives of Pharmacology 273(1): 62-74
1972
ISSN/ISBN: 0028-1298 PMID: 4338396 DOI: 10.1007/bf00508080
Accession: 042164925
Full Text Article emailed within 0-6 h: $19.90
Related References
Allen, D.O.; Clark, J.F.; Ashmore, J. 1973: Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells Journal of Pharmacology and Experimental Therapeutics 185(2): 379-385Schönhöfer, P.S.; Skidmore, I.F.; Bourne, H.R.; Krishna, G. 1972: Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline Pharmacology 7(2): 65-77
Fredholm, B.B.; Lindgren, E. 1984: The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells Acta Pharmacologica et Toxicologica 54(1): 64-71
Skidmore, I.F.; Schönhöfer, P.S.; Kritchevsky, D. 1971: Effects of nicotinic acid and some of its homologues on lipolysis, adenyl cyclase, phosphodiesterase and cyclic AMP accumulation in isolated fat cells Pharmacology 6(6): 330-338
Hosono, K.; Suzuki, H. 1983: Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. III. Inhibition of cyclic AMP phosphodiesterase Journal of Antibiotics 36(6): 679-683
Beavo, J.A.; Rogers, N.L.; Crofford, O.B.; Baird, C.E.; Hardman, J.G.; Sutherland, E.W.; Newman, E.V. 1971: Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis Annals of the new York Academy of Sciences 185: 129-136
Kupiecki, F.P. 1973: Lipolysis and reesterification: effects of some inhibitors of adenosine 3',5'-cyclic monophosphate phosphodiesterase Journal of Lipid Research 14(2): 250-254
Fredholm, B.B.; Hjemdahl, P. 1976: Inhibition by acidosis of adenosine 3',5'-cyclic monophosphate accumulation and lipolysis in isolated rat fat cells Acta Physiologica Scandinavica 96(2): 160-169
Iwai, H. 1974: Inhibition of protein kinase and cyclic AMP phosphodiesterase by eritadenine isoamyl ester. a possible mechanism for its biphasic effects on cyclic AMP-dependent lipolysis, steroidogenesis and amino acid uptake Journal of Biochemistry 76(2): 419-429
Schwabe, U.; Ebert, R. 1972: Different effects of lipolytic hormones and phosphodiesterase inhibitors on cyclic 3',5'-AMP levels in isolated fat cells Naunyn-Schmiedeberg's Archives of Pharmacology 274(3): 287-298
Tsukahara, T.; Hanazawa, S.; Murakami-Murofushi, K. 2011: Cyclic phosphatidic acid influences the expression and regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 cells Biochemical and Biophysical Research Communications 404(1): 109-114
Coates, W.J.; Connolly, B.; Dhanak, D.; Flynn, S.T.; Worby, A. 1993: Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase Journal of Medicinal Chemistry 36(10): 1387-1392
Sims, N.R.; Horvath, L.B.; Carnegie, P.R. 1979: Detergent activation and solubilization of 2':3'-cyclic nucleotide 3'-phosphodiesterase from isolated myelin and c6 cells Biochemical Journal 181(2): 367-375
Muller, B.; Lugnier, C.; Stoclet, J.C. 1990: Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria Journal of Cardiovascular Pharmacology 15(3): 444-451
Prigent, A.F.; Fougier, S.; Nemoz, G.; Anker, G.; Pacheco, H.; Lugnier, C.; Lebec, A.; Stoclet, J.C. 1988: Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta. Separation and inhibition by selective reference phosphodiesterase inhibitors Biochemical Pharmacology 37(19): 3671-3681
Cheng, J.B.; Pillar, J.S.; Marshall, S.C.; Gabel, C.A.; Shirley, J.T. 1994: Characterization of type IV phosphodiesterase in U-937 cells Activation of cyclic AMP efflux caused by inhibition of PDEIV FASEB Journal 8(4-5): A371
D'souza, T.; Dryer, S.E. 1995: Effects of phosphodiesterase inhibitors and forskolin on cyclic GMP-activated channels in intact isolated cells of the chick pineal gland Neurochemistry International 27(6): 527-533
Shafer, S.H.; Phelps, S.H.; Williams, C.L. 1996: Inhibition of DNA synthesis by cyclic AMP phosphodiesterase inhibitors in small cell lung carcinoma and SK-N-SH cells does not correlate with mobilization of intracellular calcium Molecular Biology of the Cell 7(Suppl ): 350A
Glass, W.F.; Moore, J.B. 1979: Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors Biochemical Pharmacology 28(7): 1107-1112
Vohra, M.M. 1984: Effect of cyclic AMP, db-cyclic AMP and phosphodiesterase inhibitors on histamine inhibition of the contractile response of the mouse as deferens Collection Securite 14(1): 11-20